SYNDAX PHARMACEUTICALS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.98 USD | -3.54% |
|
-6.31% | -2.45% |
| May. 08 | Syndax Pharmaceuticals Q1 Net Loss Widens | MT |
| May. 08 | Transcript : Syndax Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Other Biotechnology & Medical Research | -2.90% | -6.31% | -2.45% | -0.33% | +187.98% | 1.85B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- SNDX Stock
- Charts Syndax Pharmaceuticals, Inc.
- Comparison Chart